These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10632677)

  • 1. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.
    Mizuno M; Nishikawa K; Morgan BP; Matsuo S
    Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of C5a in the development of thrombotic glomerulonephritis in rats.
    Kondo C; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Matsuo S
    Clin Exp Immunol; 2001 May; 124(2):323-9. PubMed ID: 11422211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats.
    Strachan AJ; Woodruff TM; Haaima G; Fairlie DP; Taylor SM
    J Immunol; 2000 Jun; 164(12):6560-5. PubMed ID: 10843715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats.
    Mizuno M; Nishikawa K; Goodfellow RM; Piddlesden SJ; Morgan BP; Matsuo S
    Arthritis Rheum; 1997 Mar; 40(3):527-33. PubMed ID: 9082941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
    Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
    Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
    Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.
    Fischetti F; Durigutto P; Macor P; Marzari R; Carretta R; Tedesco F
    Arthritis Rheum; 2007 Apr; 56(4):1187-97. PubMed ID: 17393439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
    Abe M; Shibata K; Akatsu H; Shimizu N; Sakata N; Katsuragi T; Okada H
    J Immunol; 2001 Oct; 167(8):4651-60. PubMed ID: 11591795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat.
    Short A; Wong AK; Finch AM; Haaima G; Shiels IA; Fairlie DP; Taylor SM
    Br J Pharmacol; 1999 Feb; 126(3):551-4. PubMed ID: 10188960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships of human C5a and C5aR.
    Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA
    J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide.
    Mizuno M; Nishikawa K; Okada N; Matsuo S; Ito K; Okada H
    J Immunol; 1999 May; 162(9):5477-82. PubMed ID: 10228027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.
    Matsuo S; Ichida S; Takizawa H; Okada N; Baranyi L; Iguchi A; Morgan BP; Okada H
    J Exp Med; 1994 Nov; 180(5):1619-27. PubMed ID: 7525834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury.
    Bhatia M; Saluja AK; Singh VP; Frossard JL; Lee HS; Bhagat L; Gerard C; Steer ML
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G974-8. PubMed ID: 11292607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs.
    Rothermel E; Götze O; Zahn S; Schlaf G
    Scand J Immunol; 2000 Oct; 52(4):401-10. PubMed ID: 11013012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the C5-C5a receptor axis.
    Woodruff TM; Nandakumar KS; Tedesco F
    Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD59 in experimental glomerulonephritis in rats.
    Matsuo S; Nishikage H; Yoshida F; Nomura A; Piddlesden SJ; Morgan BP
    Kidney Int; 1994 Jul; 46(1):191-200. PubMed ID: 7523753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium.
    Weisman HF; Bartow T; Leppo MK; Boyle MP; Marsh HC; Carson GR; Roux KH; Weisfeldt ML; Fearon DT
    Trans Assoc Am Physicians; 1990; 103():64-72. PubMed ID: 2132543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6.
    Schieferdecker HL; Schlaf G; Koleva M; Götze O; Jungermann K
    J Immunol; 2000 May; 164(10):5453-8. PubMed ID: 10799912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells.
    Schieferdecker HL; Schlaf G; Jungermann K; Götze O
    Int Immunopharmacol; 2001 Mar; 1(3):469-81. PubMed ID: 11367531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.